Unity Biotechnology Inc Sustainability Reports

Unity Biotechnology, Inc. was a biotechnology company focused on developing therapeutics to extend healthspan by targeting cellular senescence. The company specialized in clearing senescent cells to treat age-related diseases, particularly retinal and ophthalmological conditions.

Sector: Manufacturing

Country: United States

Exchange: OTC Markets

LEI: 549300WDOM0RU3CUO763

FIGI: BBG00F412FH5

4 reports from 2018 to 2023

• Unity Biotechnology Inc 2023 Form 10-K
• Unity Biotechnology Inc 2022 Form 10-K
• Unity Biotechnology Inc 2020 Form 10-K
• Unity Biotechnology Inc 2018 Form 10-K